Market Place
Sourcing Support
MIMEDX to Participate in Upcoming Investor Conferences
04 Nov 2024 //
GLOBENEWSWIRE
MIMEDX Announces Q3 2024 Operating and Financial Results
30 Oct 2024 //
GLOBENEWSWIRE
MIMEDX to Host Q3 2024 Operating and Financial Results Call on Oct 30
14 Oct 2024 //
GLOBENEWSWIRE
MIMEDX Points To NYT Article On Placental Tissue Benefits
09 Oct 2024 //
GLOBENEWSWIRE
MIMEDX Showcases Allograft Portfolio at SAWC Fall
01 Oct 2024 //
GLOBENEWSWIRE
MIMEDX to Participate in Upcoming Investor Conferences
27 Aug 2024 //
GLOBENEWSWIRE
MiMedx Launches Heliogen For Managing Moderate To Heavy Exuding Wounds
03 Aug 2024 //
PHARMABIZ
MIMEDX Announces Second Quarter 2024 Operating and Financial Results
31 Jul 2024 //
GLOBENEWSWIRE
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
31 Jul 2024 //
GLOBENEWSWIRE
MIMEDX Publishes On Placental Allografts In Nature - Scientific Reports
22 Jul 2024 //
GLOBENEWSWIRE
MIMEDX To Host Q2 Results Call On July 31
17 Jul 2024 //
GLOBENEWSWIRE
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer
26 Jun 2024 //
GLOBENEWSWIRE
MIMEDX to Participate in Upcoming Investor Conferences
15 May 2024 //
GLOBENEWSWIRE
MIMEDX Announces First Quarter 2024 Operating and Financial Results
30 Apr 2024 //
GLOBENEWSWIRE
MIMELDX to Host Q1 2024 Results Conference Call on April 30
16 Apr 2024 //
GLOBENEWSWIRE
MIMEDX Announces Fourth Quarter and Full Year 2023 Financial Results
28 Feb 2024 //
GLOBENEWSWIRE
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference
20 Feb 2024 //
GLOBENEWSWIRE
MIMEDX Announces Capital Structure with New Senior Secured Credit Facilities
22 Jan 2024 //
GLOBENEWSWIRE
MiMedx receives FDA warning letter over Axiofill manufacturing concerns
09 Jan 2024 //
ENDPTS
MiMedx reports US FDA warning letter for Axiofill, shares drop
29 Dec 2023 //
REUTERS
MIMEDX Announces Conversion of Series B Preferred Stock to Common Stock
28 Dec 2023 //
GLOBENEWSWIRE
MIMEDX to Highlight Published Data at SAWC Fall
02 Nov 2023 //
GLOBENEWSWIRE
MIMEDX to Host Third Quarter 2023 Operating and Financial Results Conference
16 Oct 2023 //
GLOBENEWSWIRE
MIMEDX Announces Launch of EPIEFFECT
26 Sep 2023 //
GLOBENEWSWIRE
MIMEDX to Present at Upcoming Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
01 Aug 2023 //
GLOBENEWSWIRE
MIMEDX to Host Q2 2023 Financial Results Conference Call on August 1
18 Jul 2023 //
GLOBENEWSWIRE
MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case
11 Jul 2023 //
GLOBENEWSWIRE
MIMEDX Appoints Doug Rice as Chief Financial Officer
05 Jul 2023 //
GLOBENEWSWIRE
MIMEDX Announces Chief Financial Officer Transition
23 Mar 2023 //
GLOBENEWSWIRE
MIMEDX Comments on Recent Data Brief Published by Office of Inspector General
16 Mar 2023 //
GLOBENEWSWIRE
MIMEDX Announces Q4 and Full Year 2022 Operating and Financial Results
28 Feb 2023 //
GLOBENEWSWIRE
MIMEDX to Host Fourth Quarter and Full Year 2022 Financial Results
15 Feb 2023 //
GLOBENEWSWIRE
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
30 Jan 2023 //
GLOBENEWSWIRE
MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations
09 Jan 2023 //
GLOBENEWSWIRE
MIMEDX Announces Commercial Launch of EPIFIX in Japan with Agreement with GUNZE
04 Jan 2023 //
GLOBENEWSWIRE
MIMEDX Announces Wound Surgical Product Pipeline Expansion Agreement with Turn
08 Dec 2022 //
GLOBENEWSWIRE
MIMEDX to Host Third Quarter 2022 Financial Results Conference on November 2
19 Oct 2022 //
GLOBENEWSWIRE
MIMEDX Appoints Matt Notarianni as Head of Investor Relations
04 Oct 2022 //
GLOBENEWSWIRE
MIMEDX Announces Launch of AXIOFILL™
20 Sep 2022 //
GLOBENEWSWIRE
MIMEDX EPIFIX® Receives Reimbursement Approval in Japan
12 Sep 2022 //
GLOBENEWSWIRE
MIMEDX Announces Leadership Transition
06 Sep 2022 //
GLOBENEWSWIRE
MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference
04 Aug 2022 //
GLOBENEWSWIRE
MIMEDX Announces Second Quarter 2022 Operating and Financial Results
02 Aug 2022 //
GLOBENEWSWIRE
MIMEDX to Host Q2 2022 Operating and Financial Results Conference Call
20 Jul 2022 //
GLOBENEWSWIRE
MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer
18 Jul 2022 //
GLOBENEWSWIRE
MIMEDX Engages Nordic Bioscience Clinical Development for Registrational Trials
15 Jun 2022 //
GLOBENEWSWIRE
MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting
07 Jun 2022 //
GLOBENEWSWIRE
MIMEDX Reminds Shareholders to Pre-Register for Annual Meeting of Shareholders
03 Jun 2022 //
GLOBENEWSWIRE
MIMEDX Addresses Presentation by Prescience Point
02 Jun 2022 //
GLOBENEWSWIRE
MIMEDX Receives $4.6M Award from the Department of Defense
31 May 2022 //
GLOBENEWSWIRE
MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow Shareholders
31 May 2022 //
GLOBENEWSWIRE
ISS Recommends that MIMEDX Shareholders Vote for all of the Company`s Proposals
25 May 2022 //
GLOBENEWSWIRE
MIMEDX Shareholders Vote FOR ALL of the Company`s Proposals
20 May 2022 //
GLOBENEWSWIRE
MIMEDX Investor Presentation Highlights Clear Strategy for Value Creation
18 May 2022 //
GLOBENEWSWIRE
MIMEDX Mails Letter to Shareholders
16 May 2022 //
GLOBENEWSWIRE
MIMEDX Comments on Prescience Point`s False and Misleading Statements
09 May 2022 //
GLOBENEWSWIRE
MIMEDX to Participate at Upcoming Investor Conferences
05 May 2022 //
GLOBENEWSWIRE
MIMEDX Announces First Quarter 2022 Operating and Financial Results
03 May 2022 //
GLOBENEWSWIRE
MIMEDX Comments on Prescience Point`s Recent Filing
29 Apr 2022 //
GLOBENEWSWIRE
